Dietary Flavonoids and the Risk of Colorectal Cancer
Top Cited Papers
- 1 April 2007
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 16 (4) , 684-693
- https://doi.org/10.1158/1055-9965.epi-06-0785
Abstract
In vitro and in vivo laboratory data point to chemoprotective effects of flavonoids on colorectal cancer. However, there has been limited epidemiologic research on the dietary intake of flavonoids and risk of colorectal cancer. Recent expansions of dietary databases to include flavonoid data now make such studies feasible. Association between the six main classes of flavonoids and the risk of colorectal cancer was examined using data from a national prospective case-control study in Scotland, including 1,456 incident cases and 1,456 population-based controls matched on age, sex, and residence area. Dietary, including flavonoid data, were obtained from a validated, self-administered food frequency questionnaire. Risk of colorectal cancer was estimated using conditional logistic regression models in the whole sample and stratified by sex, smoking status, and cancer site and adjusted for established and putative risk factors. After energy adjustment, reductions in colorectal cancer risk associated with the highest quartiles of intake (versus the lowest quartile) were 27% for flavonols [odds ratio (OR), 0.73; Ptrend = 0.012], 32% for quercetin (OR, 0.68; Ptrend = 0.001), 32% for catechin (OR, 0.68; Ptrend < 0.0005); 26% for epicatechin (OR, 0.74; Ptrend = 0.019), and 22% for procyanidins (OR, 0.78; Ptrend = 0.031). The significant dose-dependent reductions in colorectal cancer risk that were associated with increased consumption of flavonols, quercetin, catechin, and epicatechin remained robust after controlling for overall fruit and vegetable consumption or for other flavonoid intake. The risk reductions were greater among nonsmokers, but no interaction beyond a multiplicative effect was present. Sex-specific or cancer-type differences were not observed. No risk reductions were associated with intake of flavones (Ptrend = 0.64), flavonones (Ptrend = 0.22), and phytoestrogens (Ptrend = 0.26). This was the first of several a priori hypotheses to be tested in this large study and showed strong and linear inverse associations of flavonoids with colorectal cancer risk. (Cancer Epidemiol Biomarkers Prev 2007;16(4):684–93)Keywords
This publication has 50 references indexed in Scilit:
- Flavonoid Intake and Colorectal Cancer Risk in Men and WomenAmerican Journal of Epidemiology, 2006
- Green tea polyphenol (−)‐epigallocatechin‐3‐gallate inhibits cyclooxygenase‐2 expression in colon carcinogenesisMolecular Carcinogenesis, 2006
- Procyanidins as Antioxidants and Tumor Cell Growth ModulatorsJournal of Agricultural and Food Chemistry, 2006
- Apple flavonoids inhibit growth of HT29 human colon cancer cells and modulate expression of genes involved in the biotransformation of xenobioticsMolecular Carcinogenesis, 2005
- Phyto-oestrogen intake in Scottish men: use of serum to validate a self-administered food-frequency questionnaire in older menEuropean Journal of Clinical Nutrition, 2005
- Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin)Carcinogenesis: Integrative Cancer Research, 2005
- Dietary intakes of fruit, vegetables, and fiber, and risk of colorectal cancer in a prospective cohort of women (United States)Cancer Causes & Control, 2005
- Quercetin decreases the expression of ErbB2 and ErbB3 proteins in HT-29 human colon cancer cellsThe Journal of Nutritional Biochemistry, 2005
- Quercetin, a potent inhibitor against β-catenin/Tcf signaling in SW480 colon cancer cellsBiochemical and Biophysical Research Communications, 2005
- Intake of specific carotenoids and flavonoids and the risk of lung cancer in women in Barcelona, SpainNutrition and Cancer, 1998